Tat-Frataxin protects dopaminergic neuronal cells against MPTP-induced toxicity in a mouse model of Parkinson's disease

Biochimie

Volumn 94, Issue 11, 2012, Pages 2448-2456

  Kim, Mi Jin ^a   Kim, Dae Won ^a   Jeong, Hoon Jae ^a   Sohn, Eun Jeong ^a   Shin, Min Jea ^a   Ahn, Eun Hee ^a   Kwon, Soon Won ^a   Kim, Young Nam ^a   Kim, Duk Soo ^b   Park, Jinseu ^a   Eum, Won Sik ^a   Hwang, Hyun Sook ^a   Choi, Soo Young ^a  

^a Hallym University   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

Frataxin; MPTP; Parkinson's disease; Protein transduction domain; Reactive oxygen species

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DNA; FRATAXIN; OXYGENASE; REACTIVE OXYGEN METABOLITE; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; ENZYME SYNTHESIS; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA;

ALDEHYDES; ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; GENE PRODUCTS, TAT; HUMANS; IRON-BINDING PROTEINS; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; NEUROTOXINS; OXIDATIVE STRESS; RECOMBINANT FUSION PROTEINS; SUBSTANTIA NIGRA; SUPEROXIDE DISMUTASE; TIME FACTORS; TRANSDUCTION, GENETIC;

MUS; TETRA;

EID: 84867396560     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.07.005     Document Type: Article

References (43)

1. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 2003 819 822
2. S.J. Chinta, and J.K. Andersen Redox imbalance in Parkinson's disease Biochim. Biophys. Acta 1780 2008 1362 1367
3. A.M. Cuervo, E.S.P. Wong, and M. Martinez-Vincente Protein degradation, aggregation, and misfolding Move. Disord. 25 2010 S49 S54
4. J. Zhu, and C.T. Chu Mitochondrial dysfunction in Parkinson's disease J. Alzheimers Dis. 20 2010 S325 S334
5. M.B. de Moura, L.S. dos Santos, and B. Van Houten Mitochondrial dysfunction in neurodegenerative diseases and cancer Environ. Mol. Mutagen. 51 2010 391 405
6. K. Jomova, D. Vondrakova, M. Lawson, and M. Valko Metals, oxidative stress and neurodegenerative disorders Mol. Cell. Biochem. 345 2010 91 104
7. P.H. Reddy Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease CNS Spectr. 12 2009 8 13
8. C. Henchcliffe, and M. Flint Beal Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis Nat. Clin. Pract. Neuro. 4 2008 600 609
9. D. Marmolino Friedreich's ataxia: past, present and future Brain Res. Rev. 67 2011 311 330
10. G. Gille, and H. Reichmann Iron-dependent functions of mitochondria-relation to neurodegenration J. Neural Transm. 118 2011 349 359
11. O. Gakh, S. Park, G. Liu, L. Macomber, J.A. Imlay, G.C. Ferreira, and G. Lsaya Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity Hum. Mol. Genet. 15 2006 467 479
12. A.P. Runko, A.J. Griswold, and K.T. Min Overexpression of frataxin in the mitochondria increases resistance to oxidative stress and extends lifespan in Drosophila FEBS Lett. 582 2008 715 719
13. S.R. Schwarze, A. Ho, A. Vocero-Akbani, and S.F. Dowdy In vivo protein transduction: delivery of a biologically active protein into the mouse Science 285 1999 1569 1572
14. A. van den Berg, and S.F. Dowdy Protein transduction domain delivery of therapeutic macromolecules Curr. Opin. Biotechnol. 22 2011 888 893
15. S.Y. Kim, E.J. Sohn, D.W. Kim, H.J. Jeong, M.J. Kim, H.W. Kang, M.J. Shin, E.H. Ahn, S.W. Kwon, Y.N. Kim, H.J. Kwon, T.Y. Kim, K.S. Lee, J. Park, W.S. Eum, and S.Y. Choi Transduced PEP-1-FK506BP ameliorates atopic dermatitis in NC/Nga mice J. Invest. Dermatol. 131 2011 1477 1485
16. D.W. Kim, S.H. Lee, M.S. Jeong, E.J. Sohn, M.J. Kim, H.J. Jeong, J.J. An, S.H. Jang, M.H. Won, I.K. Hwang, S.W. Cho, T.C. Kang, K.S. Lee, J. Park, K.Y. Yoo, W.S. Eum, and S.Y. Choi Transduced Tat-SAG fusion protein protects against oxidative stress and brain ischemic insult Free Radic. Biol. Med. 48 2010 969 977
17. H.S. Choi, J.J. An, S.Y. Kim, S.H. Lee, D.W. Kim, K.Y. Yoo, M.H. Won, T.C. Kang, H.J. Kwon, J.H. Kang, S.W. Cho, O.S. Kwon, J. Park, W.S. Eum, and S.Y. Choi PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron damage in a Parkinson disease mouse model Free Radic. Biol. Med. 41 2006 1058 1068
18. S.H. Choi, S.Y. Kim, J.J. An, S.H. Lee, D.W. Kim, H.J. Ryu, N.I. Lee, S.I. Yeo, S.H. Jang, M.H. Won, T.C. Kang, H.J. Kwon, S.W. Cho, J. Kim, K.S. Lee, J. Park, W.S. Eum, and S.Y. Choi Human PEP-1-ribosomal protein S3 protects against UV-induced skin cell death FEBS Lett. 580 2006 6755 6762
19. M.J. Kim, D.W. Kim, K.Y. Yoo, E.J. Sohn, H.J. Jeong, H.W. Kang, M.J. Shin, E.H. Ahn, J.J. An, S.W. Kwon, Y.N. Kim, M.H. Won, S.W. Cho, J. Park, W.S. Eum, and S.Y. Choi Protective effects of transduced PEP-1-Frataxin protein on oxidative stress-induced neuronal cell death J. Neurol. Sci. 298 2010 64 69
20. W. Kim, D.W. Kim, B.N. Shin, D.Y. Yoo, S.M. Nam, M.J. Kim, J.H. Choi, Y.S. Yoon, M.H. Won, S.Y. Choi, and I.K. Hwang PEP-1-Frataxin significantly increases cell proliferation and neuroblast differentiation by reducing lipid peroxidation in the mouse denatat gyrus Neurochem. Res. 36 2011 2452 2458
21. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
22. D.T. Vistica, P. Skehan, D. Scudiero, A. Monks, A. Pittman, and M.R. Boyd Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production Cancer Res. 51 1991 2515 2520
23. T. Takanashi, Y. Ogura, H. Taguchi, M. Hashizoe, and Y. Honda Fluorophotometric quantitation of oxidative stress in the retina in vivo Invest. Ophthalmol. Vis. Sci. 38 1997 2721 2728
24. D.S. Kim, J.E. Kim, S.E. Kwak, K.C. Choi, D.W. Kim, O.S. Kwon, S.Y. Choi, and T.C. Kang Spatiotemporal characteristics of astroglial death in the rat hippocampo-entorhinal complex following pilocarpine-induced status epilepticus J. Comp. Neurol. 511 2008 581 598
25. J.E. Kim, S.E. Kwak, and T.C. Kang Upregulated TWIK-related acid-sensitive K(+) channel-2 in neurons and perivascular astrocytes in the hippocampus of experimental temporal lobe epilepsy Epilepsia 50 2009 654 663
26. R.L. Miller, M. James-Kracke, G.Y. Sun, and A.Y. Sun Oxidative and inflammatory pathway in Parkinson's disease Neurochem. Res. 34 2009 55 65
27. J.L. Eriksen, Z. Wszolek, and L. Petrucelli Molecular pathogenesis of Parkinson disease Arch. Neurol. 62 2005 353 357
28. B. Uttara, A. Singh, P. Zamboni, and R.T. Mahajan Oxidative stress and neurodegenerative disease: a review of upstream and downstream antioxidant therapeutic options Curr. Neuropharmacol. 7 2009 65 74
29. J.M. Mates Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology Toxicology 83 2000 83 104
30. 10 as a potential treatment J. Bioenerg. Biomembr. 36 2004 381 386
31. M. Lagouge, C. Argmann, Z. Gerhart-Hines, H. Meziane, C. Lerin, F. Daussin, N. Messadeq, J. Milne, P. Lambert, P. Elliott, B. Geny, M. Laakso, P. Puigserver, and J. Auwerx Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α Cell 127 2006 1109 1122
32. K.T. Lu, M.C. Ko, B.Y. Chen, J.C. Huang, C.W. Hsieh, M.C. Lee, R.Y. Chiou, B.S. Wung, C.H. Peng, and Y.L. Yang Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging J. Agric. Food Chem. 56 2008 6910 6913
33. P. Klivenyk, D. St Clair, M. Wermer, H.C. Yen, T. Oberley, L. Yang, and M.F. Beal Manganese superoxide dismutase overexpression attenuates MPTP toxicity Neurobiol. Dis. 5 1998 253 258
34. H. Yokoyama, H. Kuroiwa, R. Yano, and T. Araki Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease Neurol. Sci. 29 2008 293 301
35. O. Eberhardt, and J.B. Schulz Apototic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease Toxicol. Lett. 139 2003 135 151
36. T. Fukuda Neurotoxicity of MPTP Neuropathology 21 2001 323 332
37. M. Cossée, H. Puccio, A. Gansmuller, H. Koutnikova, A. Dierich, M. LeMeur, K. Fischbeck, P. Dollé, and M. Koenig Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation Hum. Mol. Genet. 9 2000 1219 1226
38. D. Chang, Q. Sha, X. Zhang, P. Liu, S. Rong, T. Han, and P. Liu The evaluation of the oxidative stress parameters in patients with primary angle-closure glaucoma Plos One 6 2011 e27218
39. F. Blandini, and M.T. Armentero Animal models of Parkinson's disease FEBS J. 279 2012 1156 1166
40. S.A. Shoichet, A.T. Bäumer, D. Stamenkovic, H. Sauer, A.F. Pfeiffer, C.R. Kahn, D. Müller-Wieland, C. Richter, and M. Ristow Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro Hum. Mol. Genet. 11 2002 815 821
41. R. Thierbach, G. Drewes, M. Fusser, A. Voigt, D. Kuhlow, U. Blume, T.J. Schulz, C. Reiche, H. Glatt, B. Epe, P. Steinberg, and M. Ristow The Friedreich's ataxia protein frataxin modulates DNA base excision repair in prokaryotes and mammals Biochem. J. 432 2010 165 172
42. G.M. Palomo, T. Gerrato, R. Garqinin, and J. Diaz-Nido Silencing of frataxin gene expression triggers p53-dependent apoptosis in human neuron-like cells Hum. Mol. Genet. 20 2011 2807 2822
43. C. Lu, R. Schoenfeld, Y. Shan, H.J. Tsai, B. Hammock, and G. Cortopassi Frataxin deficiency induces Schwann cell inflammation and death Biochim. Biophys. Acta 1792 2009 1052 1061